Aummune Overview
Aummune is a clinical stage company developing a first-of-its-kind approach for individualized treatment of solid tumors. Its proprietary platform utilizes a unique efficacy-driven selection process to match and produce a patient-specific tri-functional oligonucleotide drug that safely and synergistically induces cancer cell death and activates both innate and adaptive immune responses. Aummune’s lead program, AM003, has already initiated its Phase 1 clinical trial following successful demonstrations of efficacy and safety in multiple animal models. The company is now actively recruiting patients for this First-in-Human study, which targets those with locally advanced and metastatic solid tumors.
Cumulative Funding Raised Over Time ($)
Latest News
No news articles.
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Seed |
| Rounds | 1 |
| Investors | 1 |
Team Members
4
Employees: 1-10
Web & Social Links
| Website | aummune.com |
Locations
Weizmann St 6, Tel Aviv-Yafo, Israel
Photos & Videos
No files yet
Aummune Business
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentTarget Customer
Healthcare & Life SciencesLife SciencesPharmaceuticalsCore Technology
BiologicalsMoleculesTags (9)
immunotherapycancerprecision-medicinehealthcare-providersclinicspersonalized-medicinetreatmentspharmaceuticalscancer-therapyGeographic Markets
GlobalAummune Financials
Cumulative Funding Raised Over Time ($)
Private Equity Funding
Aummune Lifecycle
Cumulative Funding Raised Over Time
All Events
Aummune News
0 articlesNo news articles.
Aummune Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 10 |
| Team members | 4 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 8 classification IDs that could be used for matching.
Aummune Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 88/100 |
| Missing | video or image, news, markets, not claimed |
| BI Verification | Jenny Sotnik-Talisman |
| Registrar ID | 515674646 |
| Crunchbase | aummune |
| Creator | Jenny Sotnik-Talisman |
| Creator email | genys30@yahoo.com |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2023-08-03T00:00:00.000Z |
| Created | 2017-12-25T00:00:00.000Z |